A/C Diagnostics Unit of AntiCancer, Inc., Receives FDA Clearance for a Portable Homocysteine Test

The A/C Diagnostics unit of AntiCancer, Inc., has received FDA clearance to market its A/C Portable Enzymatic Homocysteine Assay on the A/C Diagnostic Reader. The new homocysteine assay uses a genetically-engineered enzyme specific for homocysteine. The assay will be able to serve the need for widespread testing for homocysteine, a risk factor for cardiovascular and other diseases. "The simplicity of this test enables an economical price structure for the test kit. This gives us the possibility for gaining a significant share of the homocysteine test market," said Yuying Tan, Product Manager and lead researcher for the A/C Portable Enzymatic Homocysteine Assay.

The A/C...

Want to see the full article?

• Purchase this article for only $3.00